News

Pr Nicolas Reyns

Intraoperative Visualization and the Connectome: Pr Reyns, Hemerion co-founder,  to present its experience with fluorophores and photoactive molecules

In December, Hemerion will sponsor a two-day virtual conference organized by the Society for Neuro-Oncology (SNO). Pr. Nicolas Reyns MD, PhD (University Hospital of Lille, France), co-founder of Hemerion, will participate in this conference to share our team’s experience and innovations with photoactive drugs used to enhance neurosurgery outcomes in patients. The virtual conference chaired …

Maximilen Vermandel

Hemerion awarded an Innovation Prize by Voisin Consulting Life Sciences Neighborhood

Hemerion received the Best Innovation Prize following its participation in the Voisin Consulting Neighborhood Program. Voisin Consulting Life Sciences is an international consulting practice that offers integrated solutions to development planning, manufacturing, quality and control, nonclinical and clinical testing, safety monitoring, and interactions with regulators and payers. Its initiative, Voisin Consulting Neighborhood, is a life …

Hemerion technology introduced in the Friedman Brain Institute Falls Newsletter

Researchers from the Mount Sinai Health system introduce their ambitious research and development program to fight Glioblastoma in the recent Friedman Brain Institute Falls Newsletter, including the evaluation of the Hemerion technology. Encompassing the Icahn School of Medicine and eight hospital campuses in the New York metropolitan area, Mount Sinai is internationally acclaimed for its …

Hemerion and Mount Sinai Hospital awarded the Galien MedStartup Prize for “Best Collaboration in the MedTech and Digital Health” category

Hemerion and its clinical partner Mount Sinai Health System (NYC) are collaborating to launch an ambitious clinical trial in 2022. This partnership has won the “Best Collaboration in the MedTech and Digital Health” award of the Galien Medstartup Prize: an international recognition that perfectly kickstarts the Hemerion development in the USA.  The Galien Medstartup fosters, …

Brain X-Rays

Hemerion and Mount Sinai Health System nominated for the Galien MedStartup Awards 2021

Hemerion and its clinical partner Mount Sinai Health System have been nominated for the 8th edition of the Galien MedStartUp Awards, the innovation prize created by the Galien Foundation and Business France. The Galien Medstartup fosters, recognizes and rewards excellence in scientific innovation to improve the state of human health. Since 2013, it supports the …

Hemerion ships its devices to Erasmus Hospital

Hemerion technology to be further evaluated in the DOSINDYGO multi-center clinical trial

The Hemerion technology, which associates drugs and photonic treatments against glioblastoma, is to be evaluated in the DOSINDYGO clinical trial.This new clinical trial is sponsored by CHU de Lille (PI Nicolas REYNS) and the Brussels Erasmus Hospital (PI Florence Lefranc) with the financial support of Fonds Erasme. Following the INDYGO trial which assessed the Hemerion …

Hemerion at the Brain Tumor Symposium in Miami

The Hemerion technology presented at the Miami Global Brain Tumor Symposium

Pr. Nicolas Reyns, Head of the neurosurgery oncology dept. of the University Hospital of Lille, has been developing photodynamic therapy since 2010 in partnership with the Inserm laboratory U1189 OncoThAI. He notably spearheaded ground-breaking glioblastoma treatments and co-invented the technology now developed by Hemerion. Pr. Reyns has presented his experience developing photodynamic therapy for glioblastoma …